Cas:479064-88-5 Boc-L-phe(4-F)-OH manufacturer & supplier

Chemical Name:Boc-L-phe(4-F)-OH

CAS.NO:479064-88-5

Synonyms:boc-(s)-3-amino-3-(4-fluoro-phenyl)-propionic acid;(2R)-3-(4-Fluorophenyl)-2-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)propanoic acid;Boc-L-phe(4-F)-OH;N-(tert-Butoxycarbonyl)-4-fluoro-D-phenylalanine;4-Fluoro-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-D-phenylalanine;D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-fluoro-;MFCD03427919

Molecular Formula:C₁₄H₁₈FNO₄

Molecular Weight:283.295

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:431.2±40.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.517

PSA:75.63000

Exact Mass:283.121979

LogP:3.02

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like boc-(s)-3-amino-3-(4-fluoro-phenyl)-propionic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD03427919 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(tert-Butoxycarbonyl)-4-fluoro-D-phenylalanine Use and application,D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-fluoro- technical grade,usp/ep/jp grade.

Related News: The fine and functional chemicals sector provides new growth drivers. Boc-L-phe(4-F)-OH manufacturer For Jefferies, this “has not been demonstrated to convincingly reduce Abeta plaque burden, in our view.” The firm forecasts $3 billion in global sales for gantenerumab, but at a striking 0%, “so probability so no contribution.” Boc-L-phe(4-F)-OH supplier The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. Boc-L-phe(4-F)-OH vendor The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs. Boc-L-phe(4-F)-OH factory The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.